Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Pech T et al. |
Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. |
2012 |
Transplantation |
pmid:22167049
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
Ciancio G et al. |
Randomized trial of three induction antibodies in kidney transplantation: long-term results. |
2014 |
Transplantation |
pmid:24477186
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Jindal RM et al. |
Effect of deoxyspergualin on the endocrine function of the rat pancreas. |
1993 |
Transplantation |
pmid:7504347
|
Millis JM et al. |
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. |
1996 |
Transplantation |
pmid:8629298
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Augustine JJ et al. |
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. |
2006 |
Transplantation |
pmid:16612276
|
Tan HP et al. |
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. |
2008 |
Transplantation |
pmid:19104412
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. |
2004 |
Transplantation |
pmid:14742989
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Gaber AO et al. |
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. |
2013 |
Transplantation |
pmid:23715050
|
Warty V et al. |
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. |
1988 |
Transplantation |
pmid:2458643
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|